ArticleInternational journal of molecular sciences2022

Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone/Salt-Induced Glomerular Injury.

Toshifumi Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.